Displaying drugs 4501 - 4525 of 11866 in total
Dimethyl sulfone
Experimental
Investigational
Lecithin
A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines, and phosphatidylinositols.
Experimental
Matched Description: … A complex mixture of phospholipids, glycolipids, triglycerides, phosphatidylcholines, phosphatidylethanolamines …
Matched Mixtures name: … ONE A DAY TABLET …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Matched Mixtures name: … ONE A DAY TABLET …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Estrane-3,17-dione
Estrane-3,17-dione is a potent inhibitor of isomerase.
Experimental
Matched Iupac: … (3aS,3bR,5aS,9aS,9bR,11aS)-11a-methyl-hexadecahydro-1H-cyclopenta[a]phenanthrene-1,7-dione …
Matched Description: … Estrane-3,17-dione is a potent inhibitor of isomerase. …
Matched Description: … Estrane-3,17-dione is a potent inhibitor of isomerase. …
GI heptapeptide
GI heptapeptide is under investigation in clinical trial NCT01391208 (Esophageal Protocol for Detection of Neoplasia in the Digestive Tract).
Investigational
Itacitinib
Itacitinib has been used in trials studying the treatment of Melanoma, Carcinoma, Metastatic Cancer, Endometrial Cancer, and B-cell Malignancies, among others.
Investigational
Phellodendron amurense bark
Phellodendron amurense bark is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Matched Description: … Phellodendron amurense bark is a plant/plant extract used in some OTC (over-the-counter) products. …
DAR-0100A
DAR-0100A is under investigation in clinical trial NCT01466205 (Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder).
Investigational
Matched Iupac: … (6aR,12bS)-5H,6H,6aH,7H,8H,12bH-benzo[a]phenanthridine-10,11-diol …
Matched Description: … DAR-0100A is under investigation in clinical trial NCT01466205 (Clinical Testing of a D1 Agonist for …
Matched Description: … DAR-0100A is under investigation in clinical trial NCT01466205 (Clinical Testing of a D1 Agonist for …
CoA-s-acetyl tryptamine
Experimental
Aminoimidazole carboxamide
Investigational
Heptane-1,2,3-Triol
Experimental
N(2)-(2-carboxyethyl)-L-arginine
Experimental
Carbamic Acid
Experimental
Olomoucine
Experimental
1,2-Dihydroxybenzene
Experimental
Biphenyl-2,3-Diol
Experimental
4,5-Dimethyl-1,2-phenylenediamine
Experimental
3-methyl-benzene-1,2-diol
3-methyl-benzene-1,2-diol is a solid. This compound belongs to the catechols. These are compounds containing a 1,2-benzenediol moeity. 3-methyl-benzene-1,2-diol targets the protein biphenyl-2,3-diol 1,2-dioxygenase.
Experimental
Matched Description: … 3-methyl-benzene-1,2-diol is a solid. This compound belongs to the catechols. ... These are compounds containing a 1,2-benzenediol moeity. 3-methyl-benzene-1,2-diol targets the protein …
4-Methyl-1,2-Benzenediol
Experimental
MDL72527
Experimental
Metoprine
Experimental
Meldonium
Experimental
Heptamolybdate
Experimental
Cinnamic acid
Investigational
SARS-CoV-2 Sclamp
The University of Queensland (UQ), in partnership with The Coalition for Epidemic Preparedeness Inovations (CEPI) and CSL has developed a COVID-19 candidate, SARS-CoV-2 Sclamp. The vaccine was developed using UQ’s rapid response ‘molecular clamp’ vaccine platform that locks surface proteins in a configuration that allows more robust immune responses, in...
Investigational
Matched Description: … in partnership with The Coalition for Epidemic Preparedeness Inovations (CEPI) and CSL has developed a ... developed using UQ’s rapid response ‘molecular clamp’ vaccine platform that locks surface proteins in a ... configuration that allows more robust immune responses, in combination with a well-established adjuvant …
Displaying drugs 4501 - 4525 of 11866 in total